Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Receivables - Other: 2019-2024

Historic Receivables - Other for Burning Rock Biotech (BNR) over the last 1 years, with Dec 2024 value amounting to $1.9 million.

  • Burning Rock Biotech's Receivables - Other fell 40.76% to $1.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.9 million, marking a year-over-year decrease of 40.76%. This contributed to the annual value of $1.9 million for FY2024, which is 40.76% down from last year.
  • Per Burning Rock Biotech's latest filing, its Receivables - Other stood at $1.9 million for Q4 2024, which was down 40.76% from $3.2 million recorded in Q4 2023.
  • Burning Rock Biotech's 5-year Receivables - Other high stood at $6.7 million for Q4 2021, and its period low was $32.15 during Q2 2022.
  • Over the past 3 years, Burning Rock Biotech's median Receivables - Other value was $2.6 million (recorded in 2023), while the average stood at $2.8 million.
  • Per our database at Business Quant, Burning Rock Biotech's Receivables - Other soared by 92.64% in 2021 and then crashed by 99.97% in 2022.
  • Burning Rock Biotech's Receivables - Other (Quarterly) stood at $3.5 million in 2020, then surged by 92.64% to $6.7 million in 2021, then decreased by 8.99% to $6.1 million in 2022, then crashed by 47.08% to $3.2 million in 2023, then crashed by 40.76% to $1.9 million in 2024.
  • Its Receivables - Other stands at $1.9 million for Q4 2024, versus $3.2 million for Q4 2023 and $6.1 million for Q4 2022.